Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis

作者: Carmela Iodice , Mario M. Balletta , Roberto Minutolo , Paolo Giannattasio , Stefano Tuccillo

DOI: 10.1046/J.1523-1755.2003.00015.X

关键词: Renal functionProteinuriaAngiotensin IIIrbesartanInternal medicineModerate proteinuriaEndocrinologyMembranous nephropathyMedicineRamiprilACE inhibitorNephrology

摘要: Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis. Background Elimination residual proteinuria is the novel target renoprotrection; nevertheless, whether a greater (RAS) effectively improves antiproteinuric response patients with moderate remains ill-defined. Methods We evaluated effects maximizing RAS on quantitative and qualitative ten stable nonnephrotic (2.55 ± 0.94 g/24 hours) due to primary glomerulonephritis (NPGN), normal values creatinine clearance (103 17 mL/min). The study was divided three consecutive phases: ( 1 ) four subsequent 1-month periods ramipril at dose 2.5, 5.0, 10, 20 mg/day; 2 months mg/day + irbesartan 300 3 alone. Results Maximizing not coupled any major effect renal function blood pressure; conversely, significant decrement hemoglobin levels, 0.8 g/dL average, observed during up-titration dose. 2.5 mg significantly decreased by 29%. Similar changes were detected after alone (-28%). improved either higher doses (-30% dose) or combined treatment (-33%). reduction led amelioration markers tubular damage, as testified α microglobulin (α m) excretion component sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Conclusion In NPGN patients, standard lead features suggestive damage. enhancement up maximal degree does improve levels.

参考文章(34)
A Koyama, K Yamagata, M Kobayashi, Y Yamagata, A long-term follow-up study of asymptomatic hematuria and/or proteinuria in adults Clinical Nephrology. ,vol. 45, pp. 281- 288 ,(1996)
David M. Thomas, Andrew N. Hillis, Gerald A. Coles, Malcolm Davies, John D. Williams, Enalapril Can Treat the Proteinuria of Membranous Glomerulonephritis Without Detriment to Systemic or Renal Hemodynamics American Journal of Kidney Diseases. ,vol. 18, pp. 38- 43 ,(1991) , 10.1016/S0272-6386(12)80288-5
Claudio Bazzi, Concetta Petrini, Virginia Rizza, Girolamo Arrigo, Alessandra Beltrame, Lucia Pisano, Giuseppe D[apos ]Amico, Urinary excretion of IgG and alpha(1)-microglobulin predicts clinical course better than extent of proteinuria in membranous nephropathy. American Journal of Kidney Diseases. ,vol. 38, pp. 240- 248 ,(2001) , 10.1053/AJKD.2001.26080
Gozewijn D. Laverman, Gerjan Navis, Robert H. Henning, Paul E. De Jong, Dick De Zeeuw, Dual renin-angiotensin system blockade at optimal doses for proteinuria Kidney International. ,vol. 62, pp. 1020- 1025 ,(2002) , 10.1046/J.1523-1755.2002.00536.X
Iain C. Macdougall, ACE inhibitors and erythropoietin responsiveness American Journal of Kidney Diseases. ,vol. 38, pp. 649- 651 ,(2001) , 10.1053/AJKD.2001.28027
Claudio Bazzi, Concetta Petrini, Virginia Rizza, Girolamo Arrigo, Alessandra Beltrame, Giuseppe D'Amico, Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: Clinical significance and prognostic value of low molecular weight (“tubular”) proteins American Journal of Kidney Diseases. ,vol. 29, pp. 27- 35 ,(1997) , 10.1016/S0272-6386(97)90005-6
Piero Ruggenenti, Arrigo Schieppati, Giuseppe Remuzzi, Progression, remission, regression of chronic renal diseases. The Lancet. ,vol. 357, pp. 1601- 1608 ,(2001) , 10.1016/S0140-6736(00)04728-0
Claudio Ponticelli, Margarita Villa, Giovanni Banfi, Bruno Cesana, Claudio Pozzi, Antonello Pani, Patrizia Passerini, Marco Farina, Claudio Grassi, Ambrogio Baroli, Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? American Journal of Kidney Diseases. ,vol. 34, pp. 618- 625 ,(1999) , 10.1016/S0272-6386(99)70384-7
Paolo Ferrari, Hans-Peter Marti, Marc Pfister, Felix J. Frey, Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade. Journal of Hypertension. ,vol. 20, pp. 125- 130 ,(2002) , 10.1097/00004872-200201000-00018